Literature DB >> 30421217

Palliative Care in Patients with Leukemia: When and How?

Marieberta Vidal1, David Hui2, Eduardo Bruera2.   

Abstract

PURPOSE OF REVIEW: Patients with hematologic malignancies get more aggressive treatment and the end-of-life, more ICU deaths, and prolonged hospital stays. In comparison to solid tumors, their access to palliative care and hospice is less. RECENT
FINDINGS: Multiple factors seem to play a role including curative goals, different treatment options, stronger relationship between patients and oncologist, symptom burden, and limitations of hospice care. Improving the perception of palliative care in these patients, characterizing their needs, and more education can help to increase referrals and access to palliative care. Innovative ways to improve integration between hematology-oncology and palliative care are needed.

Entities:  

Keywords:  EOL; Hematologic malignancy; Hematology; Leukemia; Palliative care; Supportive care

Mesh:

Year:  2018        PMID: 30421217     DOI: 10.1007/s11912-018-0743-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  25 in total

1.  Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.

Authors:  D Hui; S Bansal; M Park; A Reddy; J Cortes; F Fossella; E Bruera
Journal:  Ann Oncol       Date:  2015-06-03       Impact factor: 32.976

2.  Optimizing End-of-Life Care for Patients With Hematological Malignancy: Rethinking the Role of Palliative Care Collaboration.

Authors:  Hon-Wai Benjamin Cheng
Journal:  J Pain Symptom Manage       Date:  2015-02-02       Impact factor: 3.612

3.  Health care utilization and end-of-life care for older patients with acute myeloid leukemia.

Authors:  Areej R El-Jawahri; Gregory A Abel; David P Steensma; Thomas W LeBlanc; Amir T Fathi; Timothy A Graubert; Daniel J DeAngelo; Martha Wadleigh; Karen K Ballen; Julia E Foster; Eyal C Attar; Philip C Amrein; Andrew M Brunner; Richard M Stone; Jennifer S Temel
Journal:  Cancer       Date:  2015-04-29       Impact factor: 6.860

4.  Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.

Authors:  Cathy Lynn Corbett; Martina Johnstone; James McCracken Trauer; Odette Spruyt
Journal:  J Palliat Med       Date:  2013-05       Impact factor: 2.947

5.  Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.

Authors:  David Hui; Neha Didwaniya; Marieberta Vidal; Seong Hoon Shin; Gary Chisholm; Joyce Roquemore; Eduardo Bruera
Journal:  Cancer       Date:  2014-02-18       Impact factor: 6.860

6.  Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center.

Authors:  Ahmed Elsayem; Masanori Mori; Henrique A Parsons; Mark F Munsell; David Hui; Marvin O Delgado-Guay; Timotheos Paraskevopoulos; Nada A Fadul; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

7.  Diagnosis matters: the differing 
clinical trajectories for terminal prostate, 
lung and haematological cancers.

Authors:  Leeroy William; Kate Jackson; Adam Bostanci; Jennifer Ward; Peter Martin; Lise Pittman; Gaye Moore
Journal:  Aust Fam Physician       Date:  2015-07

8.  Targeted agent use in cancer patients at the end of life.

Authors:  David Hui; Meghan Sri Karuturi; Kimberson Cochien Tanco; Jung Hye Kwon; Sun-Hyun Kim; Tao Zhang; Jung Hun Kang; Gary Chisholm; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-12-01       Impact factor: 3.612

Review 9.  Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy.

Authors:  Quentin A Hill
Journal:  Blood Rev       Date:  2009-11-13       Impact factor: 8.250

10.  Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma.

Authors:  D A Howell; H-I Wang; E Roman; A G Smith; R Patmore; M J Johnson; A C Garry; M R Howard
Journal:  BMJ Support Palliat Care       Date:  2014-02-19       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.